Eur J Pediatr Surg 2020; 30(05): 413-419
DOI: 10.1055/s-0040-1716729
Review Article

Surgical Interventions for Functional Constipation: An Update

1   Deparment of Pediatric Surgery, Urogenital and Colorectal Unit, La Paz University Hospital Children Hospital, Madrid, Comunidad de Madrid, Spain
,
Marc A. Levitt
2   Department of Pediatric Surgery, Children's National Medical Center, Washington, District of Columbia, United States
› Author Affiliations

Abstract

Chronic idiopathic constipation, also known as functional constipation, is defined as difficult and infrequent defecation without an identifiable organic cause. Medical management with laxatives is effective for the majority of constipated children. However there is a subset of patients who may need evaluation by a surgeon. As constipation progresses, it can lead to fecal retention and rectal and sigmoid distension, which impairs normal colorectal motility. Surgical interventions are influenced by the results of: a rectal biopsy, transit studies, the presence of megacolon/megarectum on contrast enema, the degree of soiling/incontinence, anorectal manometry findings, and colonic motility evaluation. In this review, we describe the different surgical options available (intestinal diversion, antegrade enemas, sacral nerve stimulation, colonic resections, and Botulinum toxin injection) and provide guidance on how to choose the best procedure for a given patient.



Publication History

Received: 09 August 2020

Accepted: 17 August 2020

Article published online:
28 September 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Stuttgart · New York

 
  • References

  • 1 Koppen IJN, Kuizenga-Wessel S, Lu PL. , et al. Surgical decision-making in the management of children with intractable functional constipation: What are we doing and are we doing it right?. J Pediatr Surg 2016; 51 (10) 1607-1612
  • 2 Mugie SM, Di Lorenzo C, Benninga MA. Constipation in childhood. Nat Rev Gastroenterol Hepatol 2011; 8 (09) 502-511
  • 3 Wood RJ, Yacob D, Levitt MA. Surgical options for the management of severe functional constipation in children. Curr Opin Pediatr 2016; 28 (03) 370-379
  • 4 Siminas S, Losty PD. Current surgical management of pediatric idiopathic constipation: a systematic review of published studies. Ann Surg 2015; 262 (06) 925-933
  • 5 Halleran DR, Vilanova-Sanchez A, Rentea RM. , et al. A comparison of Malone appendicostomy and cecostomy for antegrade access as adjuncts to a bowel management program for patients with functional constipation or fecal incontinence. J Pediatr Surg 2019; 54 (01) 123-128
  • 6 Vilanova-Sánchez A, Reck CA, Wood RJ. , et al. Impact on patient care of a multidisciplinary center specializing in colorectal and pelvic reconstruction. Front Surg 2018; 5: 68
  • 7 Li C, Shanahan S, Livingston MH, Walton JM. Malone appendicostomy versus cecostomy tube insertion for children with intractable constipation: A systematic review and meta-analysis. J Pediatr Surg 2018; 53 (05) 885-891
  • 8 Church JT, Simha S, Wild LC, Teitelbaum DH, Ehrlich PF. Antegrade continence enemas improve quality of life in patients with medically-refractory encopresis. J Pediatr Surg 2017; 52 (05) 778-782
  • 9 Ayub SS, Zeidan M, Larson SD, Islam S. Long-term outcomes of antegrade continence enema in children with chronic encopresis and incontinence: what is the optimal flush to use?. Pediatr Surg Int 2019; 35 (04) 431-438
  • 10 Dolejs SC, Smith Jr. JK, Sheplock J, Croffie JM, Rescorla FJ. Contemporary short- and long-term outcomes in patients with unremitting constipation and fecal incontinence treated with an antegrade continence enema. J Pediatr Surg 2017; 52 (01) 79-83
  • 11 de Arruda VPA, Bellomo-Brandão MA, Bustorff-Silva JM, Lomazi EA. Refractory functional constipation: clinical management or appendicostomy?. J Pediatr 2018; 96 (02) 210-216
  • 12 Wong AL, Kravarusic D, Wong SL. Impact of cecostomy and antegrade colonic enemas on management of fecal incontinence and constipation: ten years of experience in pediatric population. J Pediatr Surg 2008; 43 (08) 1445-1451
  • 13 Chong C, Featherstone N, Sharif S. , et al. 5 years after an ACE: what happens then?. Pediatr Surg Int 2016; 32 (04) 397-401
  • 14 Jaffray B. What happens to children with idiopathic constipation who receive an antegrade continent enema? An actuarial analysis of 80 consecutive cases. J Pediatr Surg 2009; 44 (02) 404-407
  • 15 Villarreal J, Sood M, Zangen T. , et al. Colonic diversion for intractable constipation in children: colonic manometry helps guide clinical decisions. J Pediatr Gastroenterol Nutr 2001; 33 (05) 588-591
  • 16 Christison-Lagay ER, Rodriguez L, Kurtz M, St Pierre K, Doody DP, Goldstein AM. Antegrade colonic enemas and intestinal diversion are highly effective in the management of children with intractable constipation. J Pediatr Surg 2010; 45 (01) 213-219
  • 17 Rodriguez L, Nurko S, Flores A. Factors associated with successful decrease and discontinuation of antegrade continence enemas (ACE) in children with defecation disorders: a study evaluating the effect of ACE on colon motility. Neurogastroenterol Motil 2013; 25 (02) 140-e81
  • 18 Khoo AK, Askouni E, Basson S, Ng J, Cleeve S. How long will I have my ACE? The natural history of the antegrade continence enema stoma in idiopathic constipation. Pediatr Surg Int 2017; 33 (11) 1159-1166
  • 19 Goldman HB, Lloyd JC, Noblett KL. , et al. International Continence Society best practice statement for use of sacral neuromodulation. Neurourol Urodyn 2018; 37 (05) 1823-1848
  • 20 Thaha MA, Abukar AA, Thin NN, Ramsanahie A, Knowles CH. Sacral nerve stimulation for faecal incontinence and constipation in adults. Cochrane Database Syst Rev 2015; (08) CD004464
  • 21 Sulkowski JP, Nacion KM, Deans KJ. , et al. Sacral nerve stimulation: a promising therapy for fecal and urinary incontinence and constipation in children. J Pediatr Surg 2015; 50 (10) 1644-1647
  • 22 van Wunnik BP, Peeters B, Govaert B, Nieman FH, Benninga MA, Baeten CG. Sacral neuromodulation therapy: a promising treatment for adolescents with refractory functional constipation. Dis Colon Rectum 2012; 55 (03) 278-285
  • 23 van der Wilt AA, van Wunnik BP, Sturkenboom R. , et al. Sacral neuromodulation in children and adolescents with chronic constipation refractory to conservative treatment. Int J Colorectal Dis 2016; 31 (08) 1459-1466
  • 24 Lu PL, Koppen IJN, Orsagh-Yentis DK. , et al. Sacral nerve stimulation for constipation and fecal incontinence in children: long-term outcomes, patient benefit, and parent satisfaction. Neurogastroenterol Motil 2018; 30 (02) e13184
  • 25 Dewberry L, Trecartin A, Peña A, Pierre MS, Bischoff A. Systematic review: sacral nerve stimulation in the treatment of constipation and fecal incontinence in children with emphasis in anorectal malformation. Pediatr Surg Int 2019; 35 (09) 1009-1012
  • 26 Janssen PTJ, Meyer YM, Van Kuijk SMJ. , et al. Long-term outcome of intractable constipation treated by sacral neuromodulation: a comparison between children and adults. Colorectal Dis 2018; 20 (02) 134-143
  • 27 Lu M-L, He J, Lu S. Electrical stimulation therapy for slow transit constipation in children: a systematic review. Int J Colorectal Dis 2015; 30 (05) 697-702
  • 28 Iacona R, Ramage L, Malakounides G. Current state of neuromodulation for constipation and fecal incontinence in children: a systematic review. Eur J Pediatr Surg 2019; 29 (06) 495-503
  • 29 Yik YI, Clarke MCC, Catto-Smith AG. , et al. Slow-transit constipation with concurrent upper gastrointestinal dysmotility and its response to transcutaneous electrical stimulation. Pediatr Surg Int 2011; 27 (07) 705-711
  • 30 Kajbafzadeh A-M, Sharifi-Rad L, Nejat F, Kajbafzadeh M, Talaei H-R. Transcutaneous interferential electrical stimulation for management of neurogenic bowel dysfunction in children with myelomeningocele. Int J Colorectal Dis 2012; 27 (04) 453-458
  • 31 Vriesman MH, Wang L, Park C. , et al. Comparison of antegrade continence enema treatment and sacral nerve stimulation for children with severe functional constipation and fecal incontinence. Neurogastroenterol Motil 2020; 32 (08) e13809
  • 32 Rodriguez L, Heinz N, Nurko S. Utility of colon manometry in guiding therapy and predicting need for surgery in children with defecation disorders. J Pediatr Gastroenterol Nutr 2020; 70 (02) 232-237
  • 33 Cheng LS, Goldstein AM. Surgical management of idiopathic constipation in pediatric patients. Clin Colon Rectal Surg 2018; 31 (02) 89-98
  • 34 De La Torre L, Cogley K, Calisto J, Nace G, Correa C. Primary sigmoidectomy and appendicostomy for chronic idiopathic constipation. Pediatr Surg Int 2016; 32 (08) 767-772
  • 35 De la Torre L, Cogley K, Cabrera-Hernández MA, Frias-Mantilla JE, Wehrli LA. Transanal proximal rectosigmoidectomy. A new operation for severe chronic idiopathic constipation associated with megarectosigmoid. J Pediatr Surg 2019; 54 (11) 2311-2317
  • 36 Gasior A, Brisighelli G, Diefenbach K. , et al. Surgical management of functional constipation: preliminary report of a new approach using a laparoscopic sigmoid resection combined with a malone appendicostomy. Eur J Pediatr Surg 2017; 27 (04) 336-340
  • 37 Kirgizov IV, Minaev SV, Shishkin I, Aprosimova S, Ukhina L. Surgical treatment of idiopathic megarectum in constipated children. J Pediatr Surg 2019; 54 (07) 1379-1383
  • 38 Glasser JG, Nottingham JM, Durkin M. , et al. Case series with literature review: Surgical approach to megarectum and/or megasigmoid in children with unremitting constipation. Ann Med Surg (Lond) 2017; 26: 24-29
  • 39 Tamura R, Jaffray B. Outcomes of colonic resection for chronic idiopathic constipation in childhood. J Pediatr Surg 2020; 55 (02) 269-272
  • 40 Langer JC, Rollins MD, Levitt M. American Pediatric Surgical Association Hirschsprung Disease Interest Group. , et al. Guidelines for the management of postoperative obstructive symptoms in children with Hirschsprung disease. Pediatr Surg Int 2017; 33 (05) 523-526
  • 41 Obata S, Fukahori S, Yagi M. , et al. Internal anal sphincter achalasia: data from a nationwide survey of allied disorders of Hirschsprung's disease in Japan. Surg Today 2017; 47 (12) 1429-1433
  • 42 Fathy A, Megahed A, Barakat T, Abdalla AF. Anorectal functional abnormalities in Egyptian children with chronic functional constipation. Arab J Gastroenterol 2013; 14 (01) 6-9
  • 43 Keshtgar AS, Ward HC, Clayden GS. Pathophysiology of chronic childhood constipation: functional and morphological evaluation by anorectal manometry and endosonography and colonic transit study. J Pediatr Surg 2013; 48 (04) 806-812
  • 44 Zar-Kessler C, Kuo B, Belkind-Gerson J. Botulinum toxin injection for childhood constipation is safe and can be effective regardless of anal sphincter dynamics. J Pediatr Surg 2018; 53 (04) 693-697
  • 45 Kumar S, Ramadan S, Gupta V, Helmy S, Atta I, Alkholy A. Manometric tests of anorectal function in 90 healthy children: a clinical study from Kuwait. J Pediatr Surg 2009; 44 (09) 1786-1790
  • 46 Irani K, Rodriguez L, Doody DP, Goldstein AM. Botulinum toxin for the treatment of chronic constipation in children with internal anal sphincter dysfunction. Pediatr Surg Int 2008; 24 (07) 779-783
  • 47 Chumpitazi BP, Fishman SJ, Nurko S. Long-term clinical outcome after botulinum toxin injection in children with nonrelaxing internal anal sphincter. Am J Gastroenterol 2009; 104 (04) 976-983
  • 48 Minkes RK, Langer JC. A prospective study of botulinum toxin for internal anal sphincter hypertonicity in children with Hirschsprung's disease. J Pediatr Surg 2000; 35 (12) 1733-1736
  • 49 Keshtgar AS, Ward HC, Clayden GS. Diagnosis and management of children with intractable constipation. Semin Pediatr Surg 2004; 13 (04) 300-309
  • 50 Basson S, Charlesworth P, Healy C, Phelps S, Cleeve S. Botulinum toxin use in paediatric colorectal surgery. Pediatr Surg Int 2014; 30 (08) 833-838
  • 51 Halleran DR, Lu PL, Ahmad H. , et al. Anal sphincter botulinum toxin injection in children with functional anorectal and colonic disorders: A large institutional study and review of the literature focusing on complications. J Pediatr Surg 2019; 54 (11) 2305-2310
  • 52 Church JT, Gadepalli SK, Talishinsky T, Teitelbaum DH, Jarboe MD. Ultrasound-guided intrasphincteric botulinum toxin injection relieves obstructive defecation due to Hirschsprung's disease and internal anal sphincter achalasia. J Pediatr Surg 2017; 52 (01) 74-78
  • 53 Han-Geurts IJM, Hendrix VC, de Blaauw I, Wijnen MHWA, van Heurn ELW. Outcome after anal intrasphincteric Botox injection in children with surgically treated Hirschsprung disease. J Pediatr Gastroenterol Nutr 2014; 59 (05) 604-607
  • 54 Food US. U.S. Food and Drug Administration. Early communication about an ongoing safety review Botox and Botox Cosmetic (botulinum toxin type A) and Myobloc (botulinum toxin type B). Plast Surg Nurs 2008; 28 (03) 150-151